Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

BODITECH

Boditech Med Inc. develops products for in-vitro diagnostics and diagnostic reagents. Its products include automatic ... read more Featured Products: More products

Download Mobile App





Boditech Presents Latest IVD Solutions at ECCMID 2022

By LabMedica International staff writers
Posted on 26 Apr 2022

Boditech Med (Gang-won-do, Korea) presented its latest IVD solutions, including RDTs, fluorescence immunoassay tests, and PCR tests, at ECCMID 2022. More...

Boditech demonstrated its AFIAS-10 automated immunoassay analyzer with blood collection tube, including an all-in-one cartridge system. The CE Marked AFIAS-10 is a unique integrated sample-to-answer system that can execute 10 parallel tests for each different parameter. It provides a quick and simplified operation and reliable test results with automatically collection of sample from a blood tube. Also on display was Boditech’s ichroma II, a compact and easy-to-use, fluorescence based POCT immunoassay analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases. Alongside this, Boditech presented ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters. ichroma III accepts cartridges for various biomarkers in random sequence and processes them in a preset temperature, even combines test parameters with differing incubation period.

At this year’s ECCMID, Boditech showcased its NuActor bench-top & automated nucleic acid (RNA/DNA) extraction system used with a ready-to-use cartridge that can be stored at room temperature as a table-top extractor. It can extract concentrated high-purity nucleic acids from a small volume of samples such as blood, cultured cells, and animal tissues quickly and easily. Visitors to Boditech’s ECCMID booth also experienced ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges. ExAmplar employs relatively fast thermal cycles (~40 sec) and can deliver the DNA and RNA test results in 30 and 45~55 minutes, respectively. The system runs with dedicated 8-well plates. The reagents for the test come in a dry format, which can be stored at room temperature.

Related Links:
Boditech Med 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.